118 related articles for article (PubMed ID: 23721930)
21. [Prognostic analysis of 669 liver metastasis of colorectal cancer cases].
Ren L; Lv SX; Zhong YS; Xu JM; Wei Y; Fan J; Qin LX; Wang JH; Cheng JM; Qian S; Qin XY
Zhonghua Wei Chang Wai Ke Za Zhi; 2009 Jul; 12(4):337-41. PubMed ID: 19598013
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors for disease-free survival after preoperative chemotherapy followed by curative resection in patients with colorectal cancer harboring hepatic metastasis: a single-institute, retrospective analysis in Asia.
Yi JH; Kim H; Jung M; Shin SJ; Choi JS; Choi GH; Baik SH; Min BS; Kim NK; Ahn JB
Oncology; 2013; 85(5):283-9. PubMed ID: 24217184
[TBL] [Abstract][Full Text] [Related]
23. Serum carcinoembryonic antigen levels in patients operated for colorectal carcinoma.
Veingerl B
Wien Klin Wochenschr; 2001; 113 Suppl 3():32-8. PubMed ID: 15503618
[TBL] [Abstract][Full Text] [Related]
24. Combination of haptoglobin and osteopontin could predict colorectal cancer hepatic metastasis.
Sun L; Pan J; Peng L; Fang L; Zhao X; Sun L; Yang Z; Ran Y
Ann Surg Oncol; 2012 Jul; 19(7):2411-9. PubMed ID: 22219064
[TBL] [Abstract][Full Text] [Related]
25. APC, K-ras, and p53 gene mutations in colorectal cancer patients: correlation to clinicopathologic features and postoperative surveillance.
Hsieh JS; Lin SR; Chang MY; Chen FM; Lu CY; Huang TJ; Huang YS; Huang CJ; Wang JY
Am Surg; 2005 Apr; 71(4):336-43. PubMed ID: 15943410
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of putative circulating cancer stem cells in patients undergoing hepatic resection for colorectal liver metastasis.
Pilati P; Mocellin S; Bertazza L; Galdi F; Briarava M; Mammano E; Tessari E; Zavagno G; Nitti D
Ann Surg Oncol; 2012 Feb; 19(2):402-8. PubMed ID: 22071867
[TBL] [Abstract][Full Text] [Related]
27. Normalization of serum p53 antibody levels in patients after curative resection for colorectal cancer.
Kawahara H; Watanabe K; Enomoto H; Toyama Y; Akiba T; Yanaga K
Anticancer Res; 2013 May; 33(5):2221-5. PubMed ID: 23645779
[TBL] [Abstract][Full Text] [Related]
28. Detection of recurrences during follow-up after liver surgery for colorectal metastases: both carcinoembryonic antigen (CEA) and imaging are important.
Verberne CJ; Wiggers T; Vermeulen KM; de Jong KP
Ann Surg Oncol; 2013 Feb; 20(2):457-63. PubMed ID: 22948771
[TBL] [Abstract][Full Text] [Related]
29. [Diagnosis and treatment of colorectal liver metastases - workflow].
Grundmann RT; Hermanek P; Merkel S; Germer CT; Grundmann RT; Hauss J; Henne-Bruns D; Herfarth K; Hermanek P; Hopt UT; Junginger T; Klar E; Klempnauer J; Knapp WH; Kraus M; Lang H; Link KH; Löhe F; Merkel S; Oldhafer KJ; Raab HR; Rau HG; Reinacher-Schick A; Ricke J; Roder J; Schäfer AO; Schlitt HJ; Schön MR; Stippel D; Tannapfel A; Tatsch K; Vogl TJ;
Zentralbl Chir; 2008 Jun; 133(3):267-84. PubMed ID: 18563694
[TBL] [Abstract][Full Text] [Related]
30. [Therapeutic effects of hepatic resection in liver metastasis of colorectal cancer].
Xu JM; Zhong YS; Fan J; Zhou J; Qin LX; Niu WX; Wei Y; Ren L; Lai YH; Zhu DX; Qin XY; Wu ZH
Zhonghua Wai Ke Za Zhi; 2007 Apr; 45(7):452-4. PubMed ID: 17686299
[TBL] [Abstract][Full Text] [Related]
31. Preoperative tumor markers as prognostic factors of colorectal liver metastases.
Treska V; Topolcan O; Stanislav K; Liska V; Holubec L
Hepatogastroenterology; 2009; 56(90):317-20. PubMed ID: 19579590
[TBL] [Abstract][Full Text] [Related]
32. Inflammation-based prognostic system predicts postoperative survival of colorectal cancer patients with a normal preoperative serum level of carcinoembryonic antigen.
Ishizuka M; Nagata H; Takagi K; Iwasaki Y; Kubota K
Ann Surg Oncol; 2012 Oct; 19(11):3422-31. PubMed ID: 22576063
[TBL] [Abstract][Full Text] [Related]
33. Serum biomarkers of colorectal cancer with AU and NP20 chips including a diagnosis model.
Jin X; Lin M; Zhang H; Han Y; He Y; Zhang Q; Yu S; Chen L; Dong W; Wang W; Sun W; Yin L
Hepatogastroenterology; 2012; 59(113):124-9. PubMed ID: 22260829
[TBL] [Abstract][Full Text] [Related]
34. Therapeutic results for hepatic metastasis of colorectal cancer with special reference to effectiveness of hepatectomy: analysis of prognostic factors for 763 cases recorded at 18 institutions.
Kato T; Yasui K; Hirai T; Kanemitsu Y; Mori T; Sugihara K; Mochizuki H; Yamamoto J
Dis Colon Rectum; 2003 Oct; 46(10 Suppl):S22-31. PubMed ID: 14530655
[TBL] [Abstract][Full Text] [Related]
35. Serum proteomic profiling for the early diagnosis of colorectal cancer.
Zhu D; Wang J; Ren L; Li Y; Xu B; Wei Y; Zhong Y; Yu X; Zhai S; Xu J; Qin X
J Cell Biochem; 2013 Feb; 114(2):448-55. PubMed ID: 22961748
[TBL] [Abstract][Full Text] [Related]
36. [Preoperative molecular staging of colorectal cancers by CM10 ProteinChip and SELDI-TOF-MS analysis].
Xu WH; Chen YD; Hu Y; Yu JK; Wu XG; Jiang TJ; Zheng S; Zhang SZ
Zhonghua Zhong Liu Za Zhi; 2006 Oct; 28(10):753-7. PubMed ID: 17366787
[TBL] [Abstract][Full Text] [Related]
37. [Significance of CEA and CA 19-9 for after care of curatively resected colorectal cancers].
Stapel A; Franke U; Putzki H
Zentralbl Chir; 1992; 117(2):77-80. PubMed ID: 1315472
[TBL] [Abstract][Full Text] [Related]
38. Predictive markers of colorectal cancer liver metastases.
Govindarajan A; Paty PB
Future Oncol; 2011 Feb; 7(2):299-307. PubMed ID: 21385143
[TBL] [Abstract][Full Text] [Related]
39. Serum p53 antibody as tumor marker for follow-up of colorectal cancer after curative resection.
Tang R; Yeh CY; Wang JY; Changchien CR; Chen JS; Hsieh LL
Ann Surg Oncol; 2009 Sep; 16(9):2516-23. PubMed ID: 19565285
[TBL] [Abstract][Full Text] [Related]
40. Evaluation of CXCL10 as a novel serum marker for predicting liver metastasis and prognosis in colorectal cancer.
Toiyama Y; Fujikawa H; Kawamura M; Matsushita K; Saigusa S; Tanaka K; Inoue Y; Uchida K; Mohri Y; Kusunoki M
Int J Oncol; 2012 Feb; 40(2):560-6. PubMed ID: 22038159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
